MedPath

MicroPhage, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA

Terminated
Conditions
Bacteremia
First Posted Date
2012-07-16
Last Posted Date
2013-01-15
Lead Sponsor
MicroPhage, Inc.
Target Recruit Count
764
Registration Number
NCT01640886
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Arizona, Infectious Disease Research, Tuscon, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

UCLA Clinical Laboratory, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Medical University of South Carolina, Charleston, South Carolina, United States

Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

Completed
Conditions
Bacteremia
First Posted Date
2010-08-18
Last Posted Date
2010-08-18
Lead Sponsor
MicroPhage, Inc.
Target Recruit Count
1165
Registration Number
NCT01184339

MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial

Completed
Conditions
Bacteremia
Infection
Staphylococcal Infection
Sepsis
First Posted Date
2008-12-24
Last Posted Date
2008-12-24
Lead Sponsor
MicroPhage, Inc.
Target Recruit Count
712
Registration Number
NCT00814151
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Evanston Northwestern Healthcare Research Institute, Evanston, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Maryland Baltimore, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Medical Institute, Baltimore, Maryland, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.